Literature DB >> 30602284

Three intrasubstance failures of a LARS™ ligament used for ligament reconstruction.

V Ramsingh1, A D Yewlett1, H C Pullen1.   

Abstract

We report three cases of intrasubstance failure of a LARS™ (Ligament Augmentation and Reconstruction System) artificial ligament used for acromioclavicular joint reconstruction. The LARS™ ligament failed within four months of the index procedure. All patients underwent a revision procedure following an unsuccessful trial of conservative management. A modified second loop technique was employed during the revision procedure for all cases using the LARS™ ligament. All three patients achieved full recovery to pre-injury level function.

Entities:  

Keywords:  Acromioclavicular joint dislocation; Coracoclavicular ligament reconstruction; LARS™

Mesh：

Substances：

Year:  2019        PMID： 30602284      PMCID： PMC6400920          DOI： 10.1308/rcsann.2018.0212

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  16 in total

1.  Structural properties of the intact and the reconstructed coracoclavicular ligament complex.

Authors:  R I Harris; A L Wallace; G D Harper; J A Goldberg; D H Sonnabend; W R Walsh
Journal:  Am J Sports Med       Date:  2000 Jan-Feb       Impact factor: 6.202

2.  In vivo and in vitro cellular ingrowth into a new generation of artificial ligaments.

Authors:  K Trieb; H Blahovec; G Brand; M Sabeti; M Dominkus; R Kotz
Journal:  Eur Surg Res       Date:  2004 May-Jun       Impact factor: 1.745

3.  Acromioclavicular joint reconstruction using the Nottingham Surgilig: a preliminary report.

Authors:  Rajarshi Bhattacharya; Lorna Goodchild; Amar Rangan
Journal:  Acta Orthop Belg       Date:  2008-04       Impact factor: 0.500

4.  Acromioclavicular joint reconstruction with the LARS ligament in professional versus non-professional athletes.

Authors:  Giulio Maria Marcheggiani Muccioli; Christopher Manning; Philip Wright; Alberto Grassi; Stefano Zaffagnini; Lennard Funk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-08-23       Impact factor: 4.342

5.  Anterior cruciate ligament reconstruction with LARS artificial ligament: a multicenter study with 3- to 5-year follow-up.

Authors:  Kai Gao; Shiyi Chen; Lide Wang; Weiguo Zhang; Yifan Kang; Qirong Dong; Haibin Zhou; Linan Li
Journal:  Arthroscopy       Date:  2010-04       Impact factor: 4.772

Review 6.  Anterior cruciate ligament reconstruction with the ligament augmentation and reconstruction system: a systematic review.

Authors:  Simon D S Newman; Henry D E Atkinson; Charles A Willis-Owen
Journal:  Int Orthop       Date:  2012-09-14       Impact factor: 3.075

7.  Surgical treatment of acromioclavicular dislocation with LARS artificial ligament.

Authors:  S Giannotti; G Dell'osso; G Bugelli; N Cazzella; G Guido
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-10-30

8.  Surgical treatment of chronic acromioclavicular dislocation: comparison between two surgical procedures for anatomic reconstruction.

Authors:  Gianfranco Fraschini; Pietro Ciampi; Celeste Scotti; Rosa Ballis; Giuseppe M Peretti
Journal:  Injury       Date:  2010-10-08       Impact factor: 2.586

9.  Outcomes of arthroscopic double-bundle PCL reconstruction using the LARS artificial ligament.

Authors:  Chao-Ping Chen; Yu-Min Lin; Yung-Cheng Chiu; Hong-Wen Wu; Cheng-Hung Lee; Kwok-Man Tong; Kui-Chou Huang
Journal:  Orthopedics       Date:  2012-06       Impact factor: 1.390

10.  Evaluation of the coracoclavicular reconstruction using LARS artificial ligament in acute acromioclavicular joint dislocation.

Authors:  Nan Lu; Lei Zhu; Tianwen Ye; Aimin Chen; Xi Jiang; Zhiling Zhang; Qinghua Zhu; Qinghe Guo; Di Yang
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-06-30       Impact factor: 4.342
View more
  1 in total

1.  Radiographic features and complications following coracoclavicular ligament reconstruction.

Authors:  Brian P Kennedy; Zehava Sadka Rosenberg; Michael J Alaia; Mohammad Samim; Erin F Alaia
Journal:  Skeletal Radiol       Date:  2020-01-11       Impact factor: 2.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.